- LATEST
- WEBSTORY
- TRENDING
BUSINESS
Aurobindo Pharma gets USFDA nod for generic version of Pfizer's Revatio tablets
The product is expected to be launched in the fourth quarter of the current fiscal.
Updated : Mar 20, 2018, 06:35 AM IST
 "Aurobindo Pharma")
TRENDING NOW
)
AR Rahman, Saira Banu's daughter Raheema opens up on parents' divorce being linked to Mohini Dey: 'Always remember...'
)
Riddhima Kapoor Sahni reveals Rishi Kapoor's last two wishes: 'He wanted to see Ranbir Kapoor getting...'
)
Sana Khan, former Bigg Boss contestant, actress announces 2nd pregnancy with Anas Saiyad: 'Only Allah has power to..'
)
'Good to be back': After breaking up with Malaika Arora, Arjun Kapoor reunites with his 'partner-in-crime after ages'
)
'Your dance lightens up...': Little girl's dance on 'Tere Bina na Guzara E' steals hearts online, WATCH viral video
)
Amid divorce rumours with Aishwarya Rai, Abhishek Bachchan tells Amitabh Bachchan: 'I hope people don't...'
)
This Pakistani Influencer's private video leaked online, days after Minahil Malik and Insha Rehman's clips
)
After breakup with Malaika Arora, Arjun Kapoor dedicates his new tattoo to this special person in his life
)
32-year-old superstar forcibly kissed 15-year-old co-star; left her traumatised, crying; later laughed about it saying..
)
Shillong Teer Results TODAY November 22, 2024 Live Updates: Check winning numbers here
)
Amid Aishwarya Rai-Abhishek Bachchan divorce rumours, Jaya Bachchan says 'not my daughter' in viral video
)
Telecom rules to change from January 1, Mukesh Ambani's Jio, Airtel, Vi, BSNL will be affected due to...
)
Gandii Baat, XXX actress Aabha Paul sets Instagram on fire with hot photos
)
Meet Mathira Khan, Pakistani influencer whose private video leaked after Minahil Malik, Imsha Rehman
)
Shweta Tiwari's wedding photos with Bigg Boss 13 contestant Vishal Aditya Singh go viral, here's the truth behind them
Aurobindo Pharma on Saturday received final approval from the USFDA to manufacture and market generic version of Pfizer's Revatio (sildenafil citrate) tablets used in the treatment of high blood pressure in lungs.
"The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Sildenafil Tablets, 20 mg", Aurobindo Pharma said in a BSE filing.
The product is expected to be launched in the fourth quarter of the current fiscal, the statement said.
"The approved Abbreviated New Drug Application (ANDA) is bioequivalent and therapeutically equivalent to Pfizer's Revatio Tablets 20 mg", the company added.
Sildenafil Tablets are used in the treatment of pulmonary arterial hypertension (high blood pressure in the lungs).
Quoting IMS data, Aurobindo Pharma said the approved product has an estimated market size of $80 million for the twelve months ended September 2015.
This is the 51st ANDA to be approved out of Unit VII formulation facility in Hyderabad for manufacturing Oral Non-Antibiotic products, the company added.
Aurobindo now has a total of 219 ANDA approvals from the USFDA.
